Employment is maintained and sick days decreased in psoriasis/psoriatic arthritis patients with etanercept treatment

Table 2 Predictive ability of baseline characteristics on employment outcomes

Independent variables (X variables used as predictors)	Dependent variables (Y variable being predicted)
Independent variables (X variables used as predictors)	Employed		Job responsibility change due to psoriasis		Job responsibility change due to PsA		Sick days
	Week 12	Week 24	Week 12	Week 24	Week 12	Week 24	Week 12	Week 24
Age	NS	NS	1.05 (1.00, 1.11)	NS	NS	1.04 (1.00, 1.09)	NS	NS
Female	NS	NS	3.1 (1.1, 9.0)	NS	NS	NS	NS	NS
Duration of psoriasis	NS	NS	NS	NS	NS	NS	NS	NS
Duration of PsA	NS	NS	NS	NS	NS	NS	NS	NS
ETN BIW/QW	5.2 (1.7, 15.7)	3.0 (1.1, 8.0)	NS	NS	NS	NS	NS	NS
Baseline job change due to psoriasis	NS	NS	22.9 (7.9, 66.3)	10.9 (4.0, 29.9)	3.1 (1.2, 8.6)	NS	2.6 (1.4, 3.8)	3.4 (1.8, 5.0)
Baseline job change due to PsA	NS	NS	NS	NS	4.9 (1.8, 12.9)	6.3 (2.7, 14.6)	NS	-1.7 (-3.0, -0.4)
Baseline sick days*	NS	0.94 (0.90, 0.99)	NS	NS	NS	NS	0.17 (0.11, 0.24)	0.15 (0.08, 0.22)
Baseline hours worked^†	1.05 (1.02, 1.08)	NS	NS	0.96 (0.93, 0.99)	0.96 (0.94, 0.98)	0.95 (0.92, 0.97)	-0.04 (-0.06, -0.01)	-0.04 (-0.07, -0.01)

NS = Not significant.
Data for all dependent variables are odds ratio (95% confidence intervals) except Sick days which show slope (95% confidence intervals). *Odds are for a one-day increase in baseline sick days. ^†Odds are for a one-hour increase in baseline hours worked.

ISSN: 1471-5945